Middle East & Africa Acne Medication Market Forecast to 2030

At 3.6% CAGR, Middle East & Africa Acne Medication Market is Speculated to be Worth US$ 548.39 Million by 2030, says the Research Team

According to the Research Team’ research, the Middle East & Africa acne medication market was valued at US$ 415.25 million in 2022 and is expected to reach US$ 548.39 million by 2030, registering a CAGR of 3.6% from 2023 to 2030. Upsurge in need for organic & natural treatments and individualized treatment programs based on cutting-edge technologies & data-driven strategies are among the critical factors attributed to the Middle East & Africa acne medication market expansion.

As people are becoming more conscious of the potentially harmful effects of synthetic ingredients and chemicals used in traditional skincare products, the demand for natural and organic alternatives that are deemed to be safer, gentler, and more environmentally friendly is on the rise across the world. Consumers are increasingly seeking products free from harsh chemicals, artificial fragrances, and potentially irritating substances, opting for formulations that harness the power of plant-based ingredients, botanical extracts, essential oils, and other natural compounds known for their skincare benefits. In response to this trend, many skincare brands and manufacturers are developing a wide range of natural and organic acne treatment products that cater to the needs of health-conscious consumers. These products often feature ingredients such as tea tree oil, witch hazel, aloe vera, green tea extract, and salicylic acid derived from natural sources, offering a more holistic and sustainable approach to treating acne without compromising efficacy. In July 2022, MÁDARA, an organic skincare business, introduced two new and natural everyday skincare products—a microbiome-balancing moisturizer and a non-drying face cleanser. The company claims that these products were developed by blending science and nature and were specifically formulated to offer gentle treatment for people of different complexions, who are prone to acne. Both products are made with natural, organic, and vegan ingredients—Northern Juniper Stem Cells, fermented polysaccharides, and lichen and Maté tea extracts—which deal specifically with imperfections, keeping the skin unharmed. Adults and teenagers can both utilize this product. Thus, the increasing preference for natural and organic acne treatment options is expected to continue shaping the future of the Middle East & Africa acne medication market in the coming years.

The shift toward natural and organic acne treatment options is also driven by the increasing stringency of regulatory scrutiny and complications associated with industry standards. Regulatory agencies emphasize ingredient transparency, safety, and sustainability, prompting companies to reformulate their products to meet evolving consumer preferences for cleaner and greener skincare solutions. Thus, as more consumers prioritize natural ingredients and eco-friendly formulations in their skincare routines, the Middle East & Africa acne medication market is expected to experience new growth trends in the coming years.

On the contrary, side effects associated with acne medication hampers the growth of Middle East & Africa acne medication market.

Based on therapeutic class, the Middle East & Africa acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held 33.5% share of the Middle East & Africa acne medication market in 2022, amassing US$ 139.09 million. It is projected to garner US$ 201.78 million by 2030 to expand at 4.8% CAGR during 2022–2030.

In terms of formulation, the Middle East & Africa acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held 68.4% share of the Middle East & Africa acne medication market in 2022, amassing US$ 283.97 million. It is estimated to garner US$ 387.82 million by 2030 to expand at 4.0% CAGR during 2022–2030.

By type, the Middle East & Africa acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held 65.2% share of Middle East & Africa acne medication market in 2022, amassing US$ 270.56 million. It is predicted to garner US$ 368.58 million by 2030 to expand at 4.0% CAGR during 2022–2030.

Based on acne type, the Middle East & Africa acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held 54.7% share of the Middle East & Africa acne medication market in 2022, amassing US$ 227.15 million. It is projected to garner US$ 305.66 million by 2030 to expand at 3.8% CAGR during 2022–2030.

In terms of distribution channel, the Middle East & Africa acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held 49.6% share of the Middle East & Africa acne medication market in 2022, amassing US$ 206.07 million. It is estimated to garner US$ 287.53 million by 2030 to expand at 4.3% CAGR during 2022–2030.

Based on country, the Middle East & Africa acne medication market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held 32.4% share of Middle East & Africa acne medication market in 2022, amassing US$ 134.71 million. It is projected to garner US$ 189.58 million by 2030 to expand at 4.4% CAGR during 2022–2030.

Key players operating in the Middle East & Africa acne medication market are Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, and Viatris Inc., among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa acne medication market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa acne medication market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Acne Medication Market Landscape
4.1 PEST Analysis
4.2 Pricing Analysis of Topical and Oral Medication
4.3 Patient Population Undergoing Acne Treatment
5. Middle East & Africa Acne Medication Market – Key Market Dynamics
5.1 Middle East & Africa Acne Medication Market – Key Market Dynamics
5.2 Key Market Drivers
5.2.1 Increasing Prevalence of Severe Acne
5.2.2 Launch of Novel Drugs
5.3 Key Market Restraints
5.3.1 Side Effects Associated with Acne Medication
5.4 Key Market Opportunities
5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
5.5 Future Trends
5.5.1 Upsurge in Need for Organic and Natural Treatments
5.6 Impact of Drivers and Restraints:
6. Acne Medication Market – Middle East & Africa Market Analysis
7. Middle East & Africa Acne Medication Market Analysis – by Therapeutic Class
7.1 Retinoids
7.1.1 Overview
7.1.2 Retinoids: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Benzoyl Peroxide
7.2.1 Overview
7.2.2 Benzoyl Peroxide: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Antibiotics
7.3.1 Overview
7.3.2 Antibiotics: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Salicylic Acid
7.4.1 Overview
7.4.2 Salicylic Acid: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Acne Medication Market Analysis – by Formulation
8.1 Topical Medication
8.1.1 Overview
8.1.2 Topical Medication: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Oral Medication
8.2.1 Overview
8.2.2 Oral Medication: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Acne Medication Market Analysis – by Type
9.1 Prescription Medicine
9.1.1 Overview
9.1.2 Prescription Medicine: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Over-the-Counter Medicine
9.2.1 Overview
9.2.2 Over-the-Counter Medicine: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Acne Medication Market Analysis – by Acne Type
10.1 Non-Inflammatory Acne
10.1.1 Overview
10.1.2 Non-Inflammatory Acne: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Inflammatory Acne
10.2.1 Overview
10.2.2 Inflammatory Acne: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Acne Medication Market Analysis – by Distribution Channel
11.1 Pharmacies and Drug Stores
11.1.1 Overview
11.1.2 Pharmacies and Drug Stores: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11.2 Retail Stores
11.2.1 Overview
11.2.2 Retail Stores: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11.3 E-Commerce
11.3.1 Overview
11.3.2 E-Commerce: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12. Middle East & Africa Acne Medication Market – Country Analysis
12.1 Middle East & Africa
12.1.1 Middle East & Africa: Acne Medication Market – Revenue and Forecast Analysis – by Country
12.1.1.1 Middle East & Africa: Acne Medication Market – Revenue and Forecast Analysis – by Country
12.1.1.2 Saudi Arabia
12.1.1.3 Saudi Arabia: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.3.1 Saudi Arabia: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.3.2 Saudi Arabia: Acne Medication Market Breakdown, by Formulation
12.1.1.3.3 Saudi Arabia: Acne Medication Market Breakdown, by Type
12.1.1.3.4 Saudi Arabia: Acne Medication Market Breakdown, by Acne Type
12.1.1.3.5 Saudi Arabia: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.4 South Africa
12.1.1.5 South Africa: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.5.1 South Africa: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.5.2 South Africa: Acne Medication Market Breakdown, by Formulation
12.1.1.5.3 South Africa: Acne Medication Market Breakdown, by Type
12.1.1.5.4 South Africa: Acne Medication Market Breakdown, by Acne Type
12.1.1.5.5 South Africa: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.6 UAE
12.1.1.7 UAE: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.7.1 UAE: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.7.2 UAE: Acne Medication Market Breakdown, by Formulation
12.1.1.7.3 UAE: Acne Medication Market Breakdown, by Type
12.1.1.7.4 UAE: Acne Medication Market Breakdown, by Acne Type
12.1.1.7.5 UAE: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.8 Rest of Middle East & Africa
12.1.1.9 Rest of Middle East & Africa: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.9.1 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.9.2 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Formulation
12.1.1.9.3 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Type
12.1.1.9.4 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Acne Type
12.1.1.9.5 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Distribution Channel
13. Acne Medication Market- Industry Landscape
13.1 Overview
13.2 Growth Strategies in Acne Medication Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
13.5 Product Offered by Farmapiel vs Other Companies Acne Products
14. Company Profiles
14.1 Teva Pharmaceutical Industries Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Almirall SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Johnson & Johnson
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bausch Health Companies Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Galderma SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 GSK Plc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Viatris Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The the Reporting Teams
15.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa Acne Medication Market Segmentation
Table 2. Topical Medication
Table 3. Oral Medication
Table 4. Patient Population undergoing Acne Treatment from 2020-2023
Table 5. Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Therapeutic Class
Table 6. Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Formulation
Table 7. Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 8. Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Acne Type
Table 9. Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 10. Middle East & Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 11. Saudi Arabia: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 12. Saudi Arabia: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 13. Saudi Arabia: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 14. Saudi Arabia: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 15. Saudi Arabia: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 16. South Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 17. South Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 18. South Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 19. South Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 20. South Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 21. UAE: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 22. UAE: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 23. UAE: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 24. UAE: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 25. UAE: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 26. Rest of Middle East & Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 27. Rest of Middle East & Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 28. Rest of Middle East & Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 29. Rest of Middle East & Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 30. Rest of Middle East & Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 31. Recent Organic Growth Strategies in Acne Medication Market
Table 32. Recent Inorganic Growth Strategies in the Acne Medication Market
Table 33. Glossary of Terms, Acne Medication Market

LIST OF FIGURES

Figure 1. Middle East & Africa Acne Medication Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Acne Medication Market Revenue (US$ Million), 2022-2030
Figure 5. Middle East & Africa Acne Medication Market Share (%) – by Therapeutic Class (2022 and 2030)
Figure 6. Retinoids: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Benzoyl Peroxide: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Antibiotics: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Salicylic Acid: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Middle East & Africa Acne Medication Market Share (%) – by Formulation (2022 and 2030)
Figure 12. Topical Medication: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Oral Medication: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Middle East & Africa Acne Medication Market Share (%) – by Type (2022 and 2030)
Figure 15. Prescription Medicine: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Over-the-Counter Medicine: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Middle East & Africa Acne Medication Market Share (%) – by Acne Type (2022 and 2030)
Figure 18. Non-Inflammatory Acne: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Inflammatory Acne: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Middle East & Africa Acne Medication Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 21. Pharmacies and Drug Stores: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Stores: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. E-Commerce: Middle East & Africa Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Middle East & Africa: Acne Medication Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. Middle East & Africa: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 26. Saudi Arabia: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. South Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. UAE: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Rest of Middle East & Africa: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in Acne Medication Market